MYC and prostate cancer: Recently, we found that 10058-F4, a chemical inhibitor of c-Myc, exerts anti-metastatic effects in LNCaP prostate cancer cells, suggesting a role of c-Myc in the metastatic progression of these prostate cancer cells (unpublished data).